CVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.
- Revenue
- +5.37%
- EPS
- +154.1%
- Free cash flow
- +3,886.7%
- Total debt
- −7.83%
Quarter to September 2026, against a year earlier
Follow CVS
Alert me
CVS Health Corporation (CVS) EV/EBITDA
As of 6 November 2026, CVS Health Corporation (CVS) trades at a EV/EBITDA of 7.8×. Over the past ten years it has ranged from 6.7× (December 2018) to 15.5× (December 2022); the current reading is higher than 16% of that period. That is below the Healthcare Plans industry median of 12.6× and below the Healthcare sector median of 8.5×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 10.3× | 20.90% |
| FY2024 | 8.5× | 0.22% |
| FY2023 | 8.5× | (34.61%) |
| FY2022 | 13.0× | 31.94% |
| FY2021 | 9.9× | 26.36% |
| FY2020 | 7.8× | (18.74%) |
| FY2019 | 9.6× | (8.50%) |
| FY2018 | 10.5× | 27.77% |
| FY2017 | 8.2× | (4.22%) |
| FY2016 | 8.6× | (26.10%) |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 7.9× | (18.04%) |
| Jun 2026 | 9.7× | 10.47% |
| Mar 2026 | 8.8× | (14.83%) |
| Dec 2025 | 10.3× | 4.58% |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| CVS CVS Health Corporation | 7.8× |
| CI Cigna Group compare | 8.1× |
| OSCR Oscar Health, Inc. compare | 8.6× |
| ELV Elevance Health, Inc. compare | 9.3× |
| CNC Centene Corporation compare | 11.8× |
| HUM Humana Inc. compare | 12.6× |
| UNH UnitedHealth Group Incorporated compare | 14.0× |
| MOH Molina Healthcare, Inc compare | 18.2× |
| PGNY Progyny, Inc. compare | 20.9× |
| Healthcare Plans industry median | 12.6× |
| Healthcare sector median | 8.5× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on CVS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement